Vanda Pharmaceuticals Inc. logo VNDA - Vanda Pharmaceuticals Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 13
HOLD 5
SELL 1
STRONG
SELL
0
| PRICE TARGET: $14.25 DETAILS
HIGH: $21.00
LOW: $7.50
MEDIAN: $14.25
CONSENSUS: $14.25
UPSIDE: 130.21%
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004
Revenue
Revenue 216.1 198.8 192.6 254.4 268.7 248.2 227.2 193.1 165.1 146.0 109.9 50.2 33.9 32.7 31.3 35.2 4.5 0 0 0 0 0.0
Cost of Revenue 13.0 11.3 14.8 24.3 25.6 23.4 24.5 20.5 17.8 24.7 23.5 1.6 0 0.1 0 4.4 2.9 0 0 0 0 0
Gross Profit 203.1 187.5 177.8 230.1 243.1 224.8 202.7 172.6 147.2 121.3 86.5 48.6 33.9 32.6 31.3 30.8 1.7 0 0 0 0 0.0
Operating Expenses
R&D Expenses 109.3 74.4 76.8 85.8 75.4 55.6 48.6 43.6 38.5 29.2 29.1 19.2 28.2 45.4 29.0 12.3 13.9 23.9 47.2 52.1 16.9 7.4
SG&A Expenses 238.0 146.4 112.9 136.5 124.0 140.5 129.7 105.8 123.8 99.8 84.5 84.6 24.6 13.9 11.5 10.1 23.7 28.9 32.8 13.6 7.4 2.1
Other Expenses 7.0 7.3 2.1 1.5 1.5 1.5 1.5 3.6 1.5 0.7 0.3 0.1 0.1 0.6 1.5 0 0 0 0 0 0 0
Operating Expenses 354.2 228.1 191.8 223.8 200.9 197.6 179.9 150.9 164.1 139.9 126.6 106.1 54.3 60.8 42.0 22.5 37.6 52.8 80.0 65.7 24.3 9.6
Operating Income
Operating Income (151.2) (40.7) (14.0) 6.3 42.2 27.2 22.8 21.7 (16.9) (18.6) (40.2) 20.1 (20.4) (28.2) (10.7) 8.3 (35.9) (52.8) (80.0) (65.7) (24.3) (9.5)
Interest Expense 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.0 0 0 0.0 0 0
Interest Income 0 0 0 0 0.2 4.4 6.2 0 0 0 0 0 0 0 0.5 0.4 0.1 1.8 5.9 2,202.7 0 0
Profitability
EBITDA (139.3) (32.5) (10.9) 9.1 45.0 34.5 25.7 24.7 (13.9) (6.7) (26.6) (54.8) (19.3) (27.1) (9.7) 10.7 (34.5) (50.5) (73.5) (62.9) (23.4) (9.2)
EBIT (151.2) (40.7) (14.0) 6.3 42.2 31.7 22.8 21.7 (16.9) (18.6) (40.2) (57.6) (21.2) (29.2) (10.7) 8.8 (35.9) (51.1) (74.1) (63.5) (23.9) (9.5)
Income Before Tax (138.6) (22.9) 6.3 11.3 42.4 31.7 29.0 25.3 (15.4) (17.9) (39.9) 20.2 (20.3) (27.7) (10.2) 9.3 (35.9) (51.1) (74.1) (63.5) (23.9) (9.5)
Income Tax Expense 81.8 (4.0) 3.8 5.0 9.2 8.3 (86.5) 0.1 0.1 0.1 0 0 0 0 (0.4) 2.1 0 0 0.0 0.0 0.0 0.0
Net Income (220.5) (18.9) 2.5 6.3 33.2 23.3 115.6 25.2 (15.6) (18.0) (39.9) 20.2 (20.3) (27.7) (9.8) 7.2 (35.9) (51.1) (74.1) (63.5) (23.9) (9.5)
Per Share Data
EPS (Basic) -3.74 -0.32 0.04 0.11 0.60 0.43 2.17 0.50 -0.35 -0.41 -0.94 0.58 -0.67 -0.98 -0.35 0.26 -1.33 -1.92 -2.81 -2.51 -0.05 -0.02
EPS (Diluted) -3.74 -0.32 0.04 0.11 0.58 0.42 2.11 0.48 -0.35 -0.41 -0.94 0.55 -0.67 -0.98 -0.35 0.25 -1.33 -1.92 -2.81 -2.51 -0.05 -0.02
Shares Outstanding 58.9 58.1 57.4 56.5 55.5 54.4 53.1 50.9 44.5 43.4 42.3 34.8 30.4 28.2 28.1 27.9 27.0 26.7 26.4 25.3 470.0 470.0
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2009 2008 2004
Current Assets
Cash & Cash Equivalents 84.9 102.3 135.8 135.0 52.1 61.0 45.1 61.0 33.6 40.4 205.3 39.1 16.3
Short-Term Investments 179.0 272.3 252.4 331.8 380.7 306.7 267.1 196.4 109.8 100.9 0 7.4 0
Net Receivables 54.6 47.1 34.2 33.5 32.5 30.0 26.4 28.8 17.6 20.3 3.3 0 0
Inventory 1.9 1.7 1.4 1.2 1.0 1.3 1.1 1.0 0.8 0.8 2.4 0 0
Other Current Assets 27.0 15.4 9.2 17.7 0 0 14.5 0 8.0 4.0 0 0 0
Total Current Assets 347.3 438.9 432.9 519.3 478.3 409.1 354.1 299.1 169.9 174.2 213.0 47.7 16.5
Non-Current Assets
Property, Plant & Equipment 13.5 12.7 9.1 11.0 12.4 14.6 15.0 4.4 5.3 5.0 1.3 1.8 1.3
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0
Intangible Assets 117.1 114.1 121.4 18.6 20.1 21.6 23.0 24.5 26.1 27.8 11.0 0 0
Long-Term Investments 0 0 0 0 0 0 0.6 0.6 0 0.8 0 0 0
Other Non-Current Assets 11.1 9.1 10.0 11.4 8.1 6.6 3.3 4.0 4.2 2.5 0.4 0.4 0.1
Total Non-Current Assets 141.7 217.3 215.5 115.0 115.5 124.3 129.6 33.0 35.6 36.2 12.8 2.2 1.3
Total Assets 488.9 656.2 648.4 634.2 593.8 533.5 483.7 332.1 205.4 210.4 225.7 49.9 17.8
Current Liabilities
Account Payables 4.9 3.5 7.1 12.7 0.9 1.0 5.9 0 0 0 2.4 0.5 0.7
Short-Term Debt 0 0 0 0 0 0 2.1 0 0 0 0 0 0.2
Deferred Revenue 0 0 0 0 0 0 0 0 0 0 26.8 0 0.7
Other Current Liabilities 97.2 69.4 69.3 34.0 27.7 45.4 44.9 41.5 50.0 (3.4) 2.2 0 0.4
Total Current Liabilities 145.2 100.0 87.7 91.4 74.4 65.9 59.5 53.0 70.4 50.3 31.5 3.4 1.6
Non-Current Liabilities
Long-Term Debt 0 0 0 0 0 0 0 0 0 0 0 0 0.1
Deferred Tax Liabilities 0 0 0 0 0 0 0 0.1 0.1 0 0 0 0
Other Non-Current Liabilities 9.5 9.6 8.8 6.8 4.4 2.8 0.8 3.7 3.7 28.7 0 0 0.0
Total Non-Current Liabilities 16.6 17.7 15.8 15.6 14.4 14.3 13.3 3.7 3.7 28.7 171.1 0.5 0.2
Total Liabilities 161.8 117.7 103.5 107.0 88.9 80.2 72.8 56.7 74.0 79.0 202.7 3.9 1.8
Stockholders' Equity
Common Stock 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0
Retained Earnings (394.8) (174.3) (155.4) (157.9) (164.2) (197.3) (220.7) (336.2) (361.4) (345.9) (260.8) (225.0) (12.4)
Accumulated Other Comprehensive Income 0.6 0.1 (0.0) (1.2) (0.2) 0.2 0.2 0.0 (0.0) 0.1 0 (0.0) (0.0)
Total Stockholders' Equity 327.2 538.5 544.9 527.2 504.9 453.3 410.9 275.4 131.4 131.3 23.0 46.0 15.9
Total Liabilities & Equity 488.9 656.2 648.4 634.2 593.8 533.5 483.7 332.1 205.4 210.4 225.7 49.9 17.8
Debt Metrics
Total Debt 12.6 12.4 9.4 11.1 12.4 13.6 14.6 0 0 0 0 0 0.4
Net Debt (72.2) (90.0) (126.4) (123.9) (39.7) (47.4) (30.5) (61.0) (33.6) (40.4) (205.3) (39.1) (15.9)
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2005 2004
Operating Activities
Net Income (220.5) (18.9) 2.5 6.3 33.2 23.3 115.6 25.2 (15.6) (18.0) (23.9) (9.5)
Depreciation & Amortization (0.9) 8.1 3.0 2.7 2.8 2.9 2.9 3.0 3.0 11.9 0.4 0.4
Stock-Based Compensation 9.5 12.4 14.0 16.3 15.4 13.4 0 11.7 10.5 8.5 0 0
Change in Working Capital 8.3 (6.6) (0.7) 6.1 2.7 4.3 3.1 (7.8) (0.0) (11.1) 0.7 0.4
Other Non-Cash Items 12.8 (4.4) (4.7) (0.5) 3.4 1.7 12.1 0.2 0.6 0.7 5.1 0.1
Operating Cash Flow (109.4) (15.8) 12.8 32.0 64.2 51.8 45.9 30.0 (2.0) (8.1) (17.7) (8.6)
Investing Activities
Capital Expenditure (1.0) (0.5) (0.4) (0.7) (0.6) (1.8) (1.0) (25.4) (1.7) (1.4) (0.3) (0.4)
Acquisitions 0 (4.2) (100.7) 0 0 0 0 25 0 0 0 0
Purchases of Investments (112.4) (364.8) (512.6) (349.3) (420.5) (346.6) (394.5) (282.4) (148.1) (165.4) (11.8) 0
Sales/Maturities of Investments 208.2 352.1 601.6 399.9 344.3 306.9 327.2 198.1 139.6 156.8 1.8 0
Other Investing Activities 0 0 0 0 0 0 0 (25) 0.1 (0.0) (0.4) 0
Investing Cash Flow 94.9 (17.4) (12.1) 49.9 (76.7) (41.5) (68.3) (109.7) (10.1) (10.1) (10.8) (0.4)
Financing Activities
Net Debt Issuance (2.0) (0.2) 0 0 0 0 0 0 0 0 (0.2) (0.2)
Stock Repurchased 0 0 0 0 0 0 0 0 0 0 0 0
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities (0.9) 0 0 0 0 0 0 6.3 5.3 7.8 0 0
Financing Cash Flow (2.9) (0.2) 0 0.7 3.5 5.6 6.3 107.1 5.3 7.8 33.3 18.1
Cash Position
Net Change in Cash (17.4) (33.5) 0.8 83.0 (9.0) 16.0 (16.0) 27.4 (6.8) (10.4) 4.8 9.1
Cash at Beginning 102.8 136.3 135.5 52.1 61.1 45.1 61.1 34.3 40.4 50.8 16.3 7.2
Cash at End 85.3 102.8 136.3 135.0 52.1 61.1 45.1 61.7 33.6 40.4 21.0 16.3
Free Cash Flow (110.4) (16.2) 12.4 31.3 63.7 50.0 44.9 4.6 (3.6) (9.5) (18.0) (9.0)
Key Metrics 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004
Income Statement
Revenue 216.1 198.8 192.6 254.4 268.7 248.2 227.2 193.1 165.1 146.0 109.9 50.2 33.9 32.7 31.3 35.2 4.5 0 0 0 0 0.0
Gross Profit 203.1 187.5 177.8 230.1 243.1 224.8 202.7 172.6 147.2 121.3 86.5 48.6 33.9 32.6 31.3 30.8 1.7 0 0 0 0 0.0
Operating Income (151.2) (40.7) (14.0) 6.3 42.2 27.2 22.8 21.7 (16.9) (18.6) (40.2) 20.1 (20.4) (28.2) (10.7) 8.3 (35.9) (52.8) (80.0) (65.7) (24.3) (9.5)
Net Income (220.5) (18.9) 2.5 6.3 33.2 23.3 115.6 25.2 (15.6) (18.0) (39.9) 20.2 (20.3) (27.7) (9.8) 7.2 (35.9) (51.1) (74.1) (63.5) (23.9) (9.5)
EPS (Diluted) -3.74 -0.32 0.04 0.11 0.58 0.42 2.11 0.48 -0.35 -0.41 -0.94 0.55 -0.67 -0.98 -0.35 0.25 -1.33 -1.92 -2.81 -2.51 -0.05 -0.02
Balance Sheet
Cash & Equivalents 84.9 102.3 135.8 135.0 52.1 61.0 45.1 61.0 33.6 40.4 205.3 39.1 16.3
Total Assets 488.9 656.2 648.4 634.2 593.8 533.5 483.7 332.1 205.4 210.4 225.7 49.9 17.8
Total Debt 12.6 12.4 9.4 11.1 12.4 13.6 14.6 0 0 0 0 0 0.4
Stockholders' Equity 327.2 538.5 544.9 527.2 504.9 453.3 410.9 275.4 131.4 131.3 23.0 46.0 15.9
Cash Flow
Operating Cash Flow (109.4) (15.8) 12.8 32.0 64.2 51.8 45.9 30.0 (2.0) (8.1) (17.7) (8.6)
Capital Expenditure (1.0) (0.5) (0.4) (0.7) (0.6) (1.8) (1.0) (25.4) (1.7) (1.4) (0.3) (0.4)
Free Cash Flow (110.4) (16.2) 12.4 31.3 63.7 50.0 44.9 4.6 (3.6) (9.5) (18.0) (9.0)